| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851067 | American Heart Journal | 2007 | 8 Pages |
Abstract
In patients with chronic Chagas cardiomyopathy, optimization of treatment with enalapril and spironolactone and subsequent addition of carvedilol were safe and associated with benefits in cardiac function and clinical status. Larger trials are needed to show effects on mortality and/or hospitalization.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Fernando A. MD, MSc, Philip A. MD, F Med Sci, Antonio L.P. MD, ScD, Darlington O. BSc, MRCP, Bráulio M.R. MD, MSc, Airandes S. MD, MSc, Mauro M. MD, ScD, Antonio L. MD, ScD, Adelina M. MD, ScD, Jackellyne B.P. MD, Cid S. MD, Wilson C. MD,